OverviewChartNewsTraderScreen

DZ Bank Knock-Out AMGN/  DE000DQ250E1  /

Frankfurt Zert./DZB
25/06/2024  18:05:06 Chg.+0.370 Bid18:11:12 Ask18:11:12 Underlying Strike price Expiration date Option type
4.220EUR +9.61% 4.200
Bid Size: 10,000		 4.220
Ask Size: 10,000		 Amgen Inc 275.8583 USD 31/12/2078 Call
GlobeNewswire 16:00 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
TeleTrader 24/06 US closes mostly lower, as energy, banking stocks take lead
GlobeNewswire 20/06 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 19/06 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 18/06 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 17/06 Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire 05/06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 30/05 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 28/05 US markets turn to losses, Dow plunges 330 points
TeleTrader 28/05 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 28/05 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 27/05 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 21/05 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 21/05 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire 21/05 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
TeleTrader 16/05 FDA approves Amgen's small cell lung cancer drug
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 14/05 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...